BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
ZBTB7A
,
cell-cell adhesion
,
Ischemia
,
Intestine
,
Autoimmunity
,
Fluoxetine
,
rs7903146
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
MAGEA3
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Testes
Superior cervical ganglion
Appendix
Testis seminiferous tubule
Atrioventricular node
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
DUB3 is a MAGEA3 deubiquitinase and a potential therapeutic target in hepatocellular carcinoma.
Probing the CRL4DCAF12 interactions with MAGEA3 and CCT5 di-Glu C-terminal degrons.
Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor pro…
Cancer testis antigen MAGEA3 in serum and serum-derived exosomes serves as a promising biomarker in …
LINC01234/MicroRNA-31-5p/MAGEA3 Axis Mediates the Proliferation and Chemoresistance of Hepatocellula…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Oncolytic MG1-MAGEA3 With Ad-MAGEA3 Vaccine in Combination With Pembrolizumab for Non-Small Cell Lun…
MG1-MAGEA3 With Ad-MAGEA3 and Pembrolizumab in Patients With Previously Treated Metastatic Melanoma …
A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1
Combination Immunotherapy and Autologous Stem Cell Transplantation for Myeloma
DNA Vaccination Against Neuroblastoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ